Evaluate and study the immunologic changes to the ocular surface in cancer patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
1. Risk factors and markers for developing eye diseases
Timeframe: Up to 4 years
2. The mechanisms of eye damage
Timeframe: Up to 4 years
The drug acting targets
Timeframe: Up to 4 years
The effect of ocular Graft-vs-Host Disease on the eye
Timeframe: Up to 4 years